Aricioglu Feyza, Yillar Okan, Korcegez Eylem, Berkman Kemal
Department of Pharmacology, Faculty of Pharmacy, Marmara University, Haydarpasa, Istanbul, Turkey.
Ann N Y Acad Sci. 2003 Dec;1009:190-5. doi: 10.1196/annals.1304.023.
The study investigated the activity of harmane on maximal electroshock seizures (MES) and seizures induced by pentilentetrazole (PTZ) in mice. Initial studies established convulsive current 50 (CC(50)) values or MES and effective dose 50 (ED(50)) for PTZ to produce seizures. Harmane (2.5, 5.0, or 10 mg/kg intraperitoneally) increased the threshold of seizures in MES dose-dependently. The convulsions produced by PTZ were decreased by the low dose of harmane (2.5 mg/kg), but the high dose of harmane (10 mg/kg) resulted in worse grade V convulsions followed by more lethality compared with PTZ alone. Therefore, harmane seems to be protective against grand mal seizures in the MES model but not against a petit mal seizure model (PTZ) in mice.
该研究调查了哈尔满对小鼠最大电休克惊厥(MES)和戊四氮(PTZ)诱导的惊厥的作用。初步研究确定了MES的惊厥电流50(CC(50))值以及PTZ诱发惊厥的半数有效剂量(ED(50))。哈尔满(腹腔注射2.5、5.0或10毫克/千克)剂量依赖性地提高了MES惊厥阈值。低剂量的哈尔满(2.5毫克/千克)可减轻PTZ引起的惊厥,但高剂量的哈尔满(10毫克/千克)与单独使用PTZ相比,会导致更严重的V级惊厥并伴有更高的致死率。因此,哈尔满似乎对MES模型中的大发作惊厥具有保护作用,但对小鼠的小发作惊厥模型(PTZ)则没有保护作用。